699 related articles for article (PubMed ID: 19027852)
1. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
[TBL] [Abstract][Full Text] [Related]
2. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
3. Investigation of drug-polymer interaction in solid dispersions by vapour sorption methods.
Punčochová K; Heng JY; Beránek J; Stěpánek F
Int J Pharm; 2014 Jul; 469(1):159-67. PubMed ID: 24751346
[TBL] [Abstract][Full Text] [Related]
4. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of polymethacrylates: impact on thermal behavior and release characteristics of glassy solid solutions.
Claeys B; De Coen R; De Geest BG; de la Rosa VR; Hoogenboom R; Carleer R; Adriaensens P; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1206-14. PubMed ID: 23485474
[TBL] [Abstract][Full Text] [Related]
6. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
7. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
[TBL] [Abstract][Full Text] [Related]
8. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
9. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
10. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
11. Controlling the Release of Indomethacin from Glass Solutions Layered with a Rate Controlling Membrane Using Fluid-Bed Processing. Part 1: Surface and Cross-Sectional Chemical Analysis.
Dereymaker A; Scurr DJ; Steer ED; Roberts CJ; Van den Mooter G
Mol Pharm; 2017 Apr; 14(4):959-973. PubMed ID: 28206770
[TBL] [Abstract][Full Text] [Related]
12. Two Contrasting Failure Modes of Enteric Coated Beads.
Shi GH; Dong X; Lytle M; Kemp CAJ; Behme RJ; Hinds J; Xiao Z
AAPS PharmSciTech; 2018 May; 19(4):1827-1836. PubMed ID: 29633154
[TBL] [Abstract][Full Text] [Related]
13. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
14. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
Grund J; Koerber M; Walther M; Bodmeier R
Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
[TBL] [Abstract][Full Text] [Related]
15. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
[TBL] [Abstract][Full Text] [Related]
16. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
17. Stabilisation of amorphous drugs under high humidity using pharmaceutical thin films.
Ng YC; Yang Z; McAuley WJ; Qi S
Eur J Pharm Biopharm; 2013 Aug; 84(3):555-65. PubMed ID: 23403014
[TBL] [Abstract][Full Text] [Related]
18. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
19. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
20. Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
Li G; Han D; Guan T; Zhao X; He H; Tang X
Int J Pharm; 2010 Nov; 400(1-2):138-44. PubMed ID: 20826202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
